EcoDrugPlus

Tachykinin Receptor 2

Ensembl ID : ENSPEMG00000017467
Gene Symbol: TACR2
1 Cross references
199 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSPEMG00000026875
Gene Symbol: TACR3
3 Cross references
256 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSPEMG00000013643
Gene Symbol: TERT
3 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSPEMG00000012189
Gene Symbol: TBXAS1
3 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSPEMG00000015376
Gene Symbol: TBXA2R
3 Cross references
192 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSPEMG00000021367
Gene Symbol: LOC102922547
3 Cross references
85 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSPEMG00000022684
Gene Symbol: TYMS
3 Cross references
223 Possible Orthologues:

Thymoma Viral Proto-Oncogene 3

Ensembl ID : ENSPEMG00000019381
Gene Symbol: AKT3
1 Cross references
201 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSPEMG00000013006
Gene Symbol: THRB
3 Cross references
392 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSPEMG00000020401
Gene Symbol: TRHR
1 Cross references
266 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSPEMG00000009603
Gene Symbol: TLR2
3 Cross references
251 Possible Orthologues:

Toll Like Receptor 4

Ensembl ID : ENSPEMG00000001134
Gene Symbol: TLR4
3 Cross references
127 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).